Effects of pyrazole partial agonists on HCA2‐mediated flushing and VLDL‐triglyceride levels in mice
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:167 |
|---|---|
| Enthalten in: |
British journal of pharmacology - 167(2012), 4 vom: Okt., Seite 818-826 |
| Beteiligte Personen: |
Li, Zhaosha [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
8 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1903977193 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1903977193 | ||
| 003 | DE-627 | ||
| 005 | 20230518034213.0 | ||
| 007 | tu | ||
| 008 | 120927s2012 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw120926_1 |
| 035 | |a (DE-627)OLC1903977193 | ||
| 035 | |a (DE-599)GBVOLC1903977193 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Li, Zhaosha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effects of pyrazole partial agonists on HCA2‐mediated flushing and VLDL‐triglyceride levels in mice |
| 264 | 1 | |c 2012 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Blad, Clara C |4 oth | |
| 700 | 1 | |a van der Sluis, Ronald J |4 oth | |
| 700 | 1 | |a de Vries, Henk |4 oth | |
| 700 | 1 | |a Van Berkel, Theo JC |4 oth | |
| 700 | 1 | |a IJzerman, Adriaan P |4 oth | |
| 700 | 1 | |a Hoekstra, Menno |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of pharmacology |d Oxford : Wiley-Blackwell, 1968 |g 167(2012), 4 vom: Okt., Seite 818-826 |w (DE-627)12926895X |w (DE-600)80081-8 |w (DE-576)014459388 |x 0007-1188 |7 nnns |
| 773 | 1 | 8 | |g volume:167 |g year:2012 |g number:4 |g month:10 |g pages:818-826 |g extent:8 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_55 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.38 |q AVZ |
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 167 |j 2012 |e 4 |c 10 |h 818-826 |g 8 | ||